IL163873A0 - Il-2 independent feline derived T cell - Google Patents

Il-2 independent feline derived T cell

Info

Publication number
IL163873A0
IL163873A0 IL16387396A IL16387396A IL163873A0 IL 163873 A0 IL163873 A0 IL 163873A0 IL 16387396 A IL16387396 A IL 16387396A IL 16387396 A IL16387396 A IL 16387396A IL 163873 A0 IL163873 A0 IL 163873A0
Authority
IL
Israel
Prior art keywords
fiv
methods
compositions
subject invention
cats
Prior art date
Application number
IL16387396A
Other languages
English (en)
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of IL163873A0 publication Critical patent/IL163873A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
IL16387396A 1995-08-25 1996-08-23 Il-2 independent feline derived T cell IL163873A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51938695A 1995-08-25 1995-08-25
PCT/US1996/013580 WO1997007817A1 (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines

Publications (1)

Publication Number Publication Date
IL163873A0 true IL163873A0 (en) 2005-12-18

Family

ID=24068097

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12326496A IL123264A0 (en) 1995-08-25 1996-08-23 Multi-subtype FIV vaccines
IL16387396A IL163873A0 (en) 1995-08-25 1996-08-23 Il-2 independent feline derived T cell
IL123264A IL123264A (en) 1995-08-25 1998-02-11 Antiviral (FIV) subtypes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL12326496A IL123264A0 (en) 1995-08-25 1996-08-23 Multi-subtype FIV vaccines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL123264A IL123264A (en) 1995-08-25 1998-02-11 Antiviral (FIV) subtypes

Country Status (17)

Country Link
US (5) US5846825A (xx)
EP (2) EP1090985B1 (xx)
JP (4) JP4142741B2 (xx)
KR (2) KR100502568B1 (xx)
AT (2) ATE297218T1 (xx)
AU (3) AU728750B2 (xx)
BR (1) BR9610343A (xx)
CA (1) CA2230029C (xx)
DE (3) DE69636440T4 (xx)
DK (2) DK0848615T3 (xx)
ES (2) ES2269042T3 (xx)
HK (1) HK1038584A1 (xx)
IL (3) IL123264A0 (xx)
NZ (3) NZ502144A (xx)
PL (2) PL188041B1 (xx)
PT (2) PT1090985E (xx)
WO (1) WO1997007817A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
PT1090985E (pt) 1995-08-25 2006-12-29 Univ California Células t derivadas de felino independentes de il-2
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US20030091987A1 (en) * 2001-02-22 2003-05-15 Yamamoto Janet K. Materials and methods for detecting, preventing, and treating retroviral infection
JP4283544B2 (ja) 2001-05-10 2009-06-24 ワイス レンチウイルスで感染した細胞培養物において細胞密度を増すための組成物および方法
CN100387301C (zh) * 2003-05-12 2008-05-14 佛罗里达大学研究基金公司 针对fiv感染的免疫接种材料和方法
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
WO2006011919A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP2007505320A (ja) * 2003-09-11 2007-03-08 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
WO2005062053A2 (en) 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7348136B2 (en) 2004-02-19 2008-03-25 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4662988B2 (ja) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスを検出するための方法および装置
CA2576930C (en) 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2009014207A1 (ja) * 2007-07-25 2009-01-29 The Kitasato Institute 猫免疫不全ウイルスワクチン接種猫の検査方法、および該検査用抗原
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8596026B2 (en) * 2010-08-05 2013-12-03 Kraft Foods Group Brands Llc Vacuum flow wrap packaging system and method of packaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
AU8007991A (en) * 1990-06-29 1992-01-23 Daniel Zagury Methods of inducing immune response to aids virus
AU2299892A (en) * 1991-07-05 1993-02-11 Regents Of The University Of California, The Feline lymphoid cell lines capable of producing fiv
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
PT1090985E (pt) * 1995-08-25 2006-12-29 Univ California Células t derivadas de felino independentes de il-2

Also Published As

Publication number Publication date
EP0848615B1 (en) 2005-06-08
US6447993B1 (en) 2002-09-10
ATE297218T1 (de) 2005-06-15
JP4413132B2 (ja) 2010-02-10
JP5339687B2 (ja) 2013-11-13
US6605282B2 (en) 2003-08-12
AU1972501A (en) 2001-05-03
EP0848615A1 (en) 1998-06-24
KR100502568B1 (ko) 2005-07-20
ES2242967T3 (es) 2005-11-16
KR100482616B1 (ko) 2005-09-02
CA2230029C (en) 2012-03-27
DE69636440D1 (de) 2006-09-21
JP2005261426A (ja) 2005-09-29
US5846825A (en) 1998-12-08
IL123264A (en) 2006-09-05
PT1090985E (pt) 2006-12-29
EP1090985A1 (en) 2001-04-11
AU6855596A (en) 1997-03-19
HK1038584A1 (en) 2002-03-22
JPH11513031A (ja) 1999-11-09
EP1090985B1 (en) 2006-08-09
US20040067242A1 (en) 2004-04-08
ATE335809T1 (de) 2006-09-15
US20080145381A1 (en) 2008-06-19
NZ316347A (en) 2000-02-28
PT848615E (pt) 2005-10-31
DE69634820D1 (de) 2005-07-14
US7311921B2 (en) 2007-12-25
JP4142741B2 (ja) 2008-09-03
ES2269042T3 (es) 2007-04-01
PL325376A1 (en) 1998-07-20
WO1997007817A1 (en) 1997-03-06
BR9610343A (pt) 1999-12-21
IL123264A0 (en) 1998-09-24
DK1090985T3 (da) 2006-12-04
PL186706B1 (pl) 2004-02-27
JP2007284442A (ja) 2007-11-01
AU772353B2 (en) 2004-04-22
NZ513388A (en) 2006-02-24
US20020172941A1 (en) 2002-11-21
DE69634820T2 (de) 2006-03-23
PL188041B1 (pl) 2004-11-30
AU728750B2 (en) 2001-01-18
KR19990044093A (ko) 1999-06-25
KR20040047812A (ko) 2004-06-05
NZ502144A (en) 2001-09-28
JP2013079286A (ja) 2013-05-02
DK0848615T3 (da) 2005-10-03
CA2230029A1 (en) 1997-03-06
DE69636440T2 (de) 2006-12-21
DE69636440T4 (de) 2007-09-27
AU2004203358A1 (en) 2004-08-19
AU2004203358B2 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
IL163873A0 (en) Il-2 independent feline derived T cell
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
AU2785089A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
NO20055857L (no) Materialer og fremgangsmater til immunisering mot FIV-infeksjon
ES8201020A1 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
AU6683400A (en) Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
DK56389A (da) Forhindring og behandling af retroviralt frembragte sygdomme
NZ220645A (en) Modified varicella-zoster virus and its cultivation
NZ334154A (en) Cross-protective equine herpes virus (EHV-1) vaccine that protects against EHV-1 and EHV-4 and method of making and using the same
Thomson IMMUNOLOGICAL AND PROTECTIVE RESPONSES TO A HERPES SIMPLEX VIRUS SUBUNIT VACCINE IN A LABIAL INFECTION MODEL IN MICE.
EP0178928A3 (en) Vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired